CRH Physicians Logo

Banding Bulletin – September 2015

On-Site Training

Comprehensive training at your office or ASC.

Schedule Now

Banding Bulletin – September 2015

We hope that this latest edition of the Banding Bulletin finds you well! With October 1st and ICD-10 coming up quickly, it was easy to pick a topic for this mailing!

ICD-10 and your banding practice

Unfortunately, since there are so many EMR’s out there, and little uniformity between practices across the country, there is no “one size fits all” solution to handling the changes that ICD-10 will present. I’ve seen some systems that require the use of ICD-9, some with ICD-10 and even some that require input of BOTH! That being said, both our “cheat sheet” and our sample super-bill are available in both formats, which can be found in the “clinical forms” section of our website HERE.

A few things to keep in mind when coding your patients:

• The CPT codes have NOT changed as of yet, and so the procedural and E&M coding for your patients should be the same as what you are familiar with.
• The vast majority of the patients you will be banding will have internal hemorrhoids with bleeding (K64.9), or be Grade II (K64.1) or Grade III (K64.2).
• The main difference between Grades II and III is that the III’s need to be manually reduced after defecation.
• All of the codes for spasm, rashes, fissures, fistulae and the like are also on the new superbill.

If your or your billers/coders/etc., have any questions regarding any of this, please feel free to reach out to JESSICA and she will try to get whatever information you need!

Bell ringing in New York!

CRH Medical reached a significant milestone this month, as we celebrated our new listing on the NYSE MKT by ringing the opening bell on September 3rd. (http://livestream.com/NYSE/CRHMedical) CRH has been a public company for some time, but previously was only listed in Canada on the TSX. CRH’s ticker symbol in the US is CRHM.

Everyone at CRH would like to thank our Partners for their support. For those of you with questions relating to the Company, please remember that I’m in charge of hemorrhoids, not investor relations! DAVID MATOUSEK is our Director of IR, and he will be happy to address any questions you might have!

CRH on the road

October signifies the start of “Conference Season”, so representatives of CRH have been, and will be, on the road, visiting the AAFP in Denver, the American College of Surgeons in Chicago, and the American College of Gastroenterology in Honolulu.

There are a number of additional conferences that we’ll be attending through the end of the year (a list can be found HERE), so if you are in the neighborhood, please stop by and say “hello”! We’ll be available to provide any support you might need, and if you’d like to set up a training or a “refresher” session, we can handle that as well!

Thanks for checking out this month’s “Banding Bulletin”! We’ll be announcing some support webinars in the coming weeks, and we hope to see you at one of the upcoming conferences or hear from you soon!

Best,
Mitch

Mitchel Guttenplan, MD, FACS
Medical Director
CRH Medical Corporation
C: 770.363.0125 F: 770.475.9953
E: mguttenplan@crhmedcorp.com
W: www.crhmedicalproducts.com

Compare CRH O'Regan System

Versus Other Hemorrhoid Treatment Options

Our account management team has over 20 years combined experience in operations, marketing and staff education for hemorrhoid banding with the CRH O’Regan System®.

If you’re a current customer, contact us today to schedule a consultation.

If you’re not utilizing the CRH O’Regan System, contact us to learn more!

Contact Us